By Helgi Library - March 28, 2025
Redcare Pharmacy made a net profit of EUR -45.5 mil with revenues of EUR 2,371 mil in 2024, down by 278% and up by 31.8...
By Helgi Library - March 27, 2025
Redcare Pharmacy employed 2,266 employees in 2024, up 9.2% compared to the previous year. Historically, between 2013 an...
By Helgi Library - March 27, 2025
Redcare Pharmacy stock traded at EUR 132 per share at the end 2024 translating into a market capitalization of USD 2,740 mil. Sin...
| Profit Statement | 2022 | 2023 | 2024 | |
| Sales | EUR mil | 1,204 | 1,799 | 2,371 |
| Gross Profit | EUR mil | 332 | 440 | 546 |
| EBITDA | EUR mil | -29.7 | 40.0 | 29.2 |
| EBIT | EUR mil | -69.2 | -17.3 | -39.0 |
| Financing Cost | EUR mil | ... | 1.78 | 1.36 |
| Pre-Tax Profit | EUR mil | -84.1 | -14.3 | -47.8 |
| Net Profit | EUR mil | -77.6 | -12.0 | -45.5 |
| Dividends | EUR mil | 0 | 0 | 0 |
| Balance Sheet | 2022 | 2023 | 2024 | |
| Total Assets | EUR mil | 729 | 1,022 | 1,003 |
| Non-Current Assets | EUR mil | 386 | 522 | 503 |
| Current Assets | EUR mil | 344 | 500 | 500 |
| Working Capital | EUR mil | 60.8 | 86.9 | 88.4 |
| Shareholders' Equity | EUR mil | 355 | 552 | 510 |
| Liabilities | EUR mil | 375 | 470 | 493 |
| Total Debt | EUR mil | 255 | 245 | 247 |
| Net Debt | EUR mil | 70.9 | 33.6 | 69.8 |
| Ratios | 2022 | 2023 | 2024 | |
| ROE | % | -20.2 | -3.11 | -8.56 |
| ROCE | % | -18.4 | -2.28 | -7.57 |
| Gross Margin | % | 27.5 | 24.5 | 23.0 |
| EBITDA Margin | % | -2.46 | 2.22 | 1.23 |
| EBIT Margin | % | -5.74 | -0.961 | -1.64 |
| Net Margin | % | -6.45 | -0.669 | -1.92 |
| Net Debt/EBITDA | -2.39 | 0.841 | 2.39 | |
| Net Debt/Equity | % | 20.0 | 6.09 | 13.7 |
| Cost of Financing | % | ... | 0.712 | 0.552 |
| Valuation | 2022 | 2023 | 2024 | |
| Market Capitalisation | USD mil | 860 | 2,895 | 2,740 |
| Enterprise Value (EV) | USD mil | 940 | 2,932 | 2,813 |
| Number Of Shares | mil | 18.0 | 19.2 | 20.1 |
| Share Price | EUR | 44.1 | 132 | 132 |
| EV/EBITDA | -28.8 | 67.6 | 88.6 | |
| EV/Sales | 0.711 | 1.50 | 1.09 | |
| Price/Earnings (P/E) | -10.2 | -180 | -58.0 | |
| Price/Book Value (P/BV) | 2.24 | 4.59 | 5.18 | |
| Dividend Yield | % | 0 | 0 | 0 |
Get all company financials in excel:
| overview | Unit | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| income statement | ||||||||||||||||||||
| Sales | EUR mil | ... | 540 | 701 | 968 | 1,060 | 1,204 | |||||||||||||
| Gross Profit | EUR mil | ... | 99.3 | 138 | 220 | 267 | 332 | |||||||||||||
| EBIT | EUR mil | ... | -28.7 | -33.4 | -0.866 | -65.7 | -69.2 | |||||||||||||
| Net Profit | EUR mil | ... | -33.6 | -36.3 | -16.8 | -74.2 | -77.6 | |||||||||||||
| ROE | % | ... | ... | -14.8 | -16.2 | -5.10 | -17.7 | -20.2 | ||||||||||||
| EBIT Margin | % | ... | -5.32 | -4.77 | -0.089 | -6.20 | -5.74 | |||||||||||||
| Net Margin | % | ... | -6.23 | -5.17 | -1.73 | -7.00 | -6.45 | |||||||||||||
| Employees | ... | 843 | 1,011 | 1,220 | 1,569 | 1,847 | ... | ... | ... | ... | ... | ... | ||||||||
| balance sheet | ||||||||||||||||||||
| Total Assets | EUR mil | ... | 350 | 428 | 537 | 783 | 729 | |||||||||||||
| Non-Current Assets | EUR mil | ... | 214 | 217 | 283 | 350 | 386 | |||||||||||||
| Current Assets | EUR mil | ... | 136 | 211 | 254 | 433 | 344 | |||||||||||||
| Shareholders' Equity | EUR mil | ... | 214 | 233 | 425 | 415 | 355 | |||||||||||||
| Liabilities | EUR mil | ... | 136 | 195 | 112 | 368 | 375 | |||||||||||||
| Non-Current Liabilities | EUR mil | ... | 83.3 | 135 | 37.2 | 244 | 256 | |||||||||||||
| Current Liabilities | EUR mil | ... | 52.7 | 59.8 | 74.6 | 124 | 119 | |||||||||||||
| Net Debt/EBITDA | ... | -1.92 | -1.94 | -5.92 | 1.22 | -2.39 | ||||||||||||||
| Net Debt/Equity | % | ... | 14.0 | 15.5 | -21.2 | -11.4 | 20.0 | |||||||||||||
| Cost of Financing | % | ... | ... | ... | ... | ... | 13.2 | 8.55 | ... | ... | ... | |||||||||
| cash flow | ||||||||||||||||||||
| Total Cash From Operations | EUR mil | ... | -18.2 | -36.4 | 4.88 | 5.29 | -35.9 | |||||||||||||
| Total Cash From Investing | EUR mil | ... | -38.6 | -33.4 | -40.3 | -84.3 | -138 | |||||||||||||
| Total Cash From Financing | EUR mil | ... | 70.2 | 108 | 63.2 | 236 | -6.45 | |||||||||||||
| Net Change In Cash | EUR mil | ... | 13.4 | 38.3 | 27.8 | 157 | -181 | |||||||||||||
| valuation | ||||||||||||||||||||
| Market Capitalisation | USD mil | ... | ... | ... | ... | 519 | 638 | 2,365 | 2,334 | 860 | ||||||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | 553 | 678 | 2,255 | 2,280 | 940 | ||||||||||
| Number Of Shares | mil | ... | 12.0 | 13.1 | 13.1 | 17.9 | 18.0 | |||||||||||||
| Share Price | EUR | ... | ... | ... | ... | 37.6 | 43.5 | 148 | 113 | 44.1 | ||||||||||
| Price/Earnings (P/E) | ... | ... | ... | ... | -13.5 | -15.6 | -115 | -27.3 | -10.2 | |||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | -15.1 | -26.5 | -177 | -32.3 | -12.4 | |||||||||||
| EV/EBITDA | ... | ... | ... | ... | -30.3 | -32.2 | 127 | -50.0 | -28.8 | |||||||||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | 2.12 | 2.44 | 4.55 | 4.88 | 2.24 | |||||||||||
| Dividend Yield | % | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 |
| income statement | Unit | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| income statement | ||||||||||||||||||||
| Sales | EUR mil | ... | 540 | 701 | 968 | 1,060 | 1,204 | |||||||||||||
| Cost of Goods & Services | EUR mil | ... | 440 | 563 | 749 | 794 | 873 | |||||||||||||
| Gross Profit | EUR mil | ... | 99.3 | 138 | 220 | 267 | 332 | |||||||||||||
| Selling, General & Admin | EUR mil | ... | 128 | 172 | 204 | 305 | 362 | ... | ... | ... | ... | ... | ... | |||||||
| Research & Development | EUR mil | ... | 0 | 0 | 0 | 0 | 0 | ... | ... | ... | ... | ... | ... | |||||||
| Other Operating Expense | EUR mil | ... | 0.002 | 0.001 | 0 | 0 | 0 | ... | ... | ... | ... | ... | ... | |||||||
| Staff Cost | EUR mil | ... | 40.0 | 54.1 | 66.9 | 120 | 129 | ... | ... | ... | ... | ... | ... | |||||||
| Other Operating Cost (Income) | EUR mil | ... | 0.196 | 0.736 | 0.065 | 0.160 | 0.149 | |||||||||||||
| EBITDA | EUR mil | ... | -15.6 | -18.6 | 15.2 | -38.7 | -29.7 | |||||||||||||
| Depreciation | EUR mil | ... | 13.2 | 14.9 | 16.1 | 27.0 | 39.5 | |||||||||||||
| EBIT | EUR mil | ... | -28.7 | -33.4 | -0.866 | -65.7 | -69.2 | |||||||||||||
| Net Financing Cost | EUR mil | ... | ... | ... | ... | ... | 5.90 | 8.84 | ... | ... | ... | |||||||||
| Financing Cost | EUR mil | ... | ... | ... | ... | ... | 6.20 | 10.2 | ... | ... | ... | |||||||||
| Financing Income | EUR mil | ... | ... | ... | ... | ... | 0.300 | 1.33 | ... | ... | ... | |||||||||
| FX (Gain) Loss | EUR mil | ... | 0 | 0 | ... | ... | ... | |||||||||||||
| (Income) / Loss from Affiliates | EUR mil | ... | ... | ... | ... | -0.104 | -0.045 | 0.427 | -0.339 | |||||||||||
| Extraordinary Cost | EUR mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Pre-Tax Profit | EUR mil | ... | -34.6 | -42.2 | -15.9 | -77.9 | -84.1 | |||||||||||||
| Tax | EUR mil | ... | -0.982 | -5.91 | 0.839 | -3.70 | -6.47 | |||||||||||||
| Minorities | EUR mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Net Profit | EUR mil | ... | -33.6 | -36.3 | -16.8 | -74.2 | -77.6 | |||||||||||||
| Net Profit Avail. to Common | EUR mil | ... | -33.6 | -36.3 | -16.8 | -74.2 | -77.6 | |||||||||||||
| Dividends | EUR mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| growth rates | ||||||||||||||||||||
| Total Revenue Growth | % | ... | ... | 90.0 | 29.9 | 38.1 | 9.53 | 13.6 | ||||||||||||
| Operating Cost Growth | % | ... | ... | 60.7 | 34.0 | 28.3 | 50.8 | 20.7 | ||||||||||||
| Staff Cost Growth | % | ... | ... | 99.9 | 35.3 | 23.8 | 78.8 | 8.21 | ... | ... | ... | ... | ... | ... | ||||||
| EBITDA Growth | % | ... | ... | 28.2 | 19.4 | -182 | -355 | -23.4 | ||||||||||||
| EBIT Growth | % | ... | ... | 49.7 | 16.4 | -97.4 | 7,486 | 5.29 | ||||||||||||
| Pre-Tax Profit Growth | % | ... | ... | 61.6 | 21.9 | -62.2 | 389 | 8.01 | ||||||||||||
| Net Profit Growth | % | ... | ... | 57.4 | 7.92 | -53.8 | 342 | 4.67 | ||||||||||||
| ratios | ||||||||||||||||||||
| ROE | % | ... | ... | -14.8 | -16.2 | -5.10 | -17.7 | -20.2 | ||||||||||||
| ROA | % | ... | ... | -10.4 | -9.33 | -3.48 | -11.2 | -10.3 | ||||||||||||
| ROCE | % | ... | ... | -13.6 | -13.9 | -5.48 | -20.1 | -18.4 | ||||||||||||
| Gross Margin | % | ... | 18.4 | 19.6 | 22.7 | 25.1 | 27.5 | |||||||||||||
| EBITDA Margin | % | ... | -2.88 | -2.65 | 1.57 | -3.65 | -2.46 | |||||||||||||
| EBIT Margin | % | ... | -5.32 | -4.77 | -0.089 | -6.20 | -5.74 | |||||||||||||
| Net Margin | % | ... | -6.23 | -5.17 | -1.73 | -7.00 | -6.45 | |||||||||||||
| Payout Ratio | % | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Cost of Financing | % | ... | ... | ... | ... | ... | 13.2 | 8.55 | ... | ... | ... | |||||||||
| Net Debt/EBITDA | ... | -1.92 | -1.94 | -5.92 | 1.22 | -2.39 |
| balance sheet | Unit | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| balance sheet | ||||||||||||||||||||
| Cash & Cash Equivalents | EUR mil | ... | 58.8 | 113 | 128 | 284 | 184 | |||||||||||||
| Receivables | EUR mil | ... | 22.1 | 26.7 | 30.0 | 27.9 | 30.0 | |||||||||||||
| Inventories | EUR mil | ... | 43.3 | 56.7 | 81.2 | 96.6 | 99.7 | |||||||||||||
| Other ST Assets | EUR mil | ... | 11.5 | 14.2 | 14.6 | 24.4 | 29.9 | |||||||||||||
| Current Assets | EUR mil | ... | 136 | 211 | 254 | 433 | 344 | |||||||||||||
| Property, Plant & Equipment | EUR mil | ... | 11.9 | 13.2 | 74.5 | 78.3 | 85.4 | |||||||||||||
| LT Investments & Receivables | EUR mil | ... | 0 | 2.50 | 1.74 | 13.1 | 9.40 | |||||||||||||
| Intangible Assets | EUR mil | ... | 200 | 200 | 205 | 257 | 289 | |||||||||||||
| Goodwill | EUR mil | ... | 129 | 129 | 129 | 153 | 170 | |||||||||||||
| Non-Current Assets | EUR mil | ... | 214 | 217 | 283 | 350 | 386 | |||||||||||||
| Total Assets | EUR mil | ... | 350 | 428 | 537 | 783 | 729 | |||||||||||||
| Trade Payables | EUR mil | ... | 26.1 | 31.4 | 51.3 | 78.1 | 68.9 | |||||||||||||
| Short-Term Debt | EUR mil | ... | 16.3 | 17.7 | 5.42 | 6.41 | 7.55 | |||||||||||||
| Other ST Liabilities | EUR mil | ... | 7.93 | 10.1 | 8.32 | 15.1 | 11.7 | |||||||||||||
| Current Liabilities | EUR mil | ... | 52.7 | 59.8 | 74.6 | 124 | 119 | |||||||||||||
| Long-Term Debt | EUR mil | ... | 72.4 | 132 | 32.8 | 230 | 248 | |||||||||||||
| Other LT Liabilities | EUR mil | ... | 10.8 | 3.90 | 4.35 | 13.6 | 7.89 | |||||||||||||
| Non-Current Liabilities | EUR mil | ... | 83.3 | 135 | 37.2 | 244 | 256 | |||||||||||||
| Liabilities | EUR mil | ... | 136 | 195 | 112 | 368 | 375 | |||||||||||||
| Preferred Equity and Hybrid Capital | EUR mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Share Capital | EUR mil | ... | 292 | 341 | 552 | 567 | 571 | |||||||||||||
| Treasury Stock | EUR mil | ... | 0 | 0 | 0 | 0 | 0 | ... | ... | |||||||||||
| Equity Before Minority Interest | EUR mil | ... | 214 | 233 | 425 | 415 | 355 | |||||||||||||
| Minority Interest | EUR mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Equity | EUR mil | ... | 214 | 233 | 425 | 415 | 355 | |||||||||||||
| growth rates | ||||||||||||||||||||
| Total Asset Growth | % | ... | ... | 17.5 | 22.3 | 25.5 | 45.8 | -6.85 | ||||||||||||
| Shareholders' Equity Growth | % | ... | ... | -10.5 | 8.78 | 82.6 | -2.29 | -14.6 | ||||||||||||
| Net Debt Growth | % | ... | ... | -229 | 20.1 | -350 | -47.4 | -250 | ||||||||||||
| Total Debt Growth | % | ... | ... | ... | ... | ... | ... | 1,658 | 68.2 | -74.4 | 518 | 7.94 | ||||||||
| ratios | ||||||||||||||||||||
| Total Debt | EUR mil | ... | 88.7 | 149 | 38.2 | 236 | 255 | |||||||||||||
| Net Debt | EUR mil | ... | 29.9 | 36.0 | -90.0 | -47.4 | 70.9 | |||||||||||||
| Working Capital | EUR mil | ... | 39.3 | 52.0 | 59.9 | 46.4 | 60.8 | |||||||||||||
| Capital Employed | EUR mil | ... | 254 | 269 | 343 | 397 | 446 | |||||||||||||
| Net Debt/Equity | % | ... | 14.0 | 15.5 | -21.2 | -11.4 | 20.0 | |||||||||||||
| Current Ratio | ... | 2.58 | 3.53 | 3.41 | 3.49 | 2.88 | ||||||||||||||
| Quick Ratio | ... | 1.53 | 2.34 | 2.12 | 2.51 | 1.80 |
| cash flow | Unit | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| cash flow | ||||||||||||||||||||
| Net Profit | EUR mil | ... | -33.6 | -36.3 | -16.8 | -74.2 | -77.6 | |||||||||||||
| Depreciation | EUR mil | ... | 13.2 | 14.9 | 16.1 | 27.0 | 39.5 | |||||||||||||
| Non-Cash Items | EUR mil | ... | 1.86 | -0.302 | 6.82 | 24.0 | 19.3 | |||||||||||||
| Change in Working Capital | EUR mil | ... | 0.379 | -14.7 | -1.24 | 28.5 | -17.0 | |||||||||||||
| Total Cash From Operations | EUR mil | ... | -18.2 | -36.4 | 4.88 | 5.29 | -35.9 | |||||||||||||
| Capital Expenditures | EUR mil | ... | -11.9 | -14.7 | -53.3 | -43.2 | -53.5 | |||||||||||||
| Net Change in LT Investment | EUR mil | ... | -0.010 | 0 | 13.1 | -10.3 | -79.1 | |||||||||||||
| Net Cash From Acquisitions | EUR mil | ... | -4.78 | 0 | 0 | -31.2 | -6.02 | |||||||||||||
| Other Investing Activities | EUR mil | ... | -21.9 | -18.7 | 0 | 0.303 | 0.300 | |||||||||||||
| Total Cash From Investing | EUR mil | ... | -38.6 | -33.4 | -40.3 | -84.3 | -138 | |||||||||||||
| Dividends Paid | EUR mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Issuance Of Shares | EUR mil | ... | 0 | 49.1 | 63.4 | 0 | 0 | |||||||||||||
| Issuance Of Debt | EUR mil | ... | 72.4 | 55.0 | -12.5 | 224 | -7.08 | |||||||||||||
| Other Financing Activities | EUR mil | ... | -2.22 | 3.97 | 12.4 | 12.2 | 0.637 | |||||||||||||
| Total Cash From Financing | EUR mil | ... | 70.2 | 108 | 63.2 | 236 | -6.45 | |||||||||||||
| Effect of FX Rates | EUR mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Net Change In Cash | EUR mil | ... | 13.4 | 38.3 | 27.8 | 157 | -181 | |||||||||||||
| ratios | ||||||||||||||||||||
| Days Sales Outstanding | days | ... | 14.9 | 13.9 | 11.3 | 9.61 | 9.09 | |||||||||||||
| Days Sales Of Inventory | days | ... | 35.9 | 36.7 | 39.6 | 44.4 | 41.7 | |||||||||||||
| Days Payable Outstanding | days | ... | 21.6 | 20.3 | 25.0 | 35.9 | 28.8 | |||||||||||||
| Cash Conversion Cycle | days | ... | 29.2 | 30.3 | 25.9 | 18.1 | 22.0 | |||||||||||||
| Cash Earnings | EUR mil | ... | -30.0 | -21.4 | -10.9 | -62.8 | -63.8 | |||||||||||||
| Free Cash Flow | EUR mil | ... | -56.8 | -69.8 | -35.4 | -79.0 | -174 | |||||||||||||
| Capital Expenditures (As % of Sales) | % | ... | 2.20 | 2.10 | 5.51 | 4.07 | 4.44 |
| other ratios | Unit | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| Employees | ... | 843 | 1,011 | 1,220 | 1,569 | 1,847 | ... | ... | ... | ... | ... | ... | ||||||||
| Cost Per Employee | USD per month | ... | 4,629 | 5,051 | 5,358 | 7,485 | 6,417 | ... | ... | ... | ... | ... | ... | |||||||
| Cost Per Employee (Local Currency) | EUR per month | ... | 3,952 | 4,457 | 4,571 | 6,354 | 5,841 | ... | ... | ... | ... | ... | ... | |||||||
| Employee Turnover | % | ... | ... | ... | ... | ... | ... | 26.0 | 38.1 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Women (As % of Workforce) | % | ... | ... | ... | ... | ... | ... | 60.9 | 59.8 | 59.2 | 42.1 | 58.2 | ... | ... | ... | ... | ... | ... | ||
| Material & Energy (As % of Sales) | % | ... | 81.6 | 80.4 | 77.3 | 74.9 | 72.5 | |||||||||||||
| Services (As % of Sales) | % | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Operating Cost (As % of Sales) | % | ... | 23.8 | 24.5 | 22.8 | 31.3 | 33.3 | |||||||||||||
| Research & Development (As % of Sales) | % | ... | 0 | 0 | 0 | 0 | 0 | ... | ... | ... | ... | ... | ... | |||||||
| Staff Cost (As % of Sales) | % | ... | 7.41 | 7.71 | 6.91 | 11.3 | 10.7 | ... | ... | ... | ... | ... | ... | |||||||
| Effective Tax Rate | % | ... | 2.84 | 14.0 | -5.27 | 4.75 | 7.70 | |||||||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | ... | 57.7 | 52.6 | 50.5 | 43.0 | 33.5 | ||||||||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Customers | mil | 3.50 | 4.70 | 6.30 | 7.90 | 9.50 |
| valuation | Unit | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| Market Capitalisation | USD mil | ... | ... | ... | ... | 519 | 638 | 2,365 | 2,334 | 860 | ||||||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | 553 | 678 | 2,255 | 2,280 | 940 | ||||||||||
| Number Of Shares | mil | ... | 12.0 | 13.1 | 13.1 | 17.9 | 18.0 | |||||||||||||
| Share Price | EUR | ... | ... | ... | ... | 37.6 | 43.5 | 148 | 113 | 44.1 | ||||||||||
| EV/EBITDA | ... | ... | ... | ... | -30.3 | -32.2 | 127 | -50.0 | -28.8 | |||||||||||
| Price/Earnings (P/E) | ... | ... | ... | ... | -13.5 | -15.6 | -115 | -27.3 | -10.2 | |||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | -15.1 | -26.5 | -177 | -32.3 | -12.4 | |||||||||||
| P/FCF | ... | ... | ... | ... | -7.98 | -8.14 | -54.7 | -25.6 | -4.55 | |||||||||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | 2.12 | 2.44 | 4.55 | 4.88 | 2.24 | |||||||||||
| Dividend Yield | % | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Free Cash Flow Yield | % | ... | ... | ... | ... | -12.8 | -12.4 | -1.75 | -3.99 | -22.3 | ||||||||||
| Earnings Per Share (EPS) | EUR | ... | -2.79 | -2.78 | -1.28 | -4.15 | -4.32 | |||||||||||||
| Cash Earnings Per Share | EUR | ... | -2.49 | -1.64 | -0.838 | -3.51 | -3.55 | |||||||||||||
| Free Cash Flow Per Share | EUR | ... | -4.71 | -5.35 | -2.71 | -4.42 | -9.69 | |||||||||||||
| Book Value Per Share | EUR | ... | 17.8 | 17.8 | 32.5 | 23.2 | 19.7 | |||||||||||||
| Dividend Per Share | EUR | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| EV/Sales | ... | ... | ... | ... | 0.875 | 0.854 | 1.99 | 1.83 | 0.711 | |||||||||||
| EV/EBIT | ... | ... | ... | ... | -16.4 | -17.9 | -2,222 | -29.5 | -12.4 | |||||||||||
| EV/Free Cash Flow | ... | ... | ... | ... | -8.32 | -8.57 | -54.4 | -24.5 | -4.91 | |||||||||||
| EV/Capital Employed | ... | ... | ... | ... | 1.90 | 2.25 | 5.39 | 5.05 | 1.86 | |||||||||||
| Earnings Per Share Growth | % | ... | ... | 24.0 | -0.358 | -53.8 | 223 | 4.10 | ||||||||||||
| Cash Earnings Per Share Growth | % | ... | ... | 25.3 | -34.2 | -48.9 | 319 | 1.03 | ||||||||||||
| Book Value Per Share Growth | % | ... | ... | -29.4 | 0.302 | 82.6 | -28.6 | -15.1 | ||||||||||||
| Market Value per Customer | USD | ... | ... | ... | ... | 148 | 136 | 375 | 295 | 90.5 | ||||||||||
| Sales per Customer | USD | ... | 181 | 169 | 180 | 158 | 139 | |||||||||||||
| EBITDA per Customer | USD | ... | -5.21 | -4.48 | 2.83 | -5.78 | -3.43 | |||||||||||||
| Net Profit per Customer | USD | ... | -11.2 | -8.74 | -3.12 | -11.1 | -8.98 |
| clients & arpu | Unit | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| Customers | mil | 3.50 | 4.70 | 6.30 | 7.90 | 9.50 | ||||||||||||||
| ARPU from Total Business | EUR per month | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||
| Basket Size (USD) | USD | ... | ... | ... | ... | 85.5 | 75.9 | 77.8 | 72.0 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Repeat Order Rate | % | ... | ... | ... | ... | 81.0 | 82.0 | 82.0 | 82.0 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Site Visits | mil | ... | ... | ... | ... | 93.1 | 134 | 208 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Get all company financials in excel:
By Helgi Library - March 27, 2025
Redcare Pharmacy made a net profit of EUR -45.5 mil with revenues of EUR 2,371 mil in 2024, down by 278% and up by 31.8%, respectively, compared to the previous year. This translates into a net margin of -1.92%. Historically, between 2013 and 2024, ...
By Helgi Library - March 27, 2025
Redcare Pharmacy made a net profit of EUR -45.5 mil in 2024, down 278% compared to the previous year. Historically, between 2013 and 2024, the company's net profit reached a high of EUR -2.83 mil in 2013 and a low of EUR -77.6 mil in 2022. The result impl...
By Helgi Library - March 27, 2025
Redcare Pharmacy invested a total of EUR 42.2 mil in 2024, up 10.3% compared to the previous year. Historically, between 2013 - 2024, the company's investments stood at a high of EUR 53.5 mil in 2022 and a low of EUR 2.30 mil in 2014. ...
By Helgi Library - March 27, 2025
Redcare Pharmacy made a net profit of EUR -45.5 mil with revenues of EUR 2,371 mil in 2024, down by 278% and up by 31.8%, respectively, compared to the previous year. This translates into a net margin of -1.92%. On the operating level, EBITDA reached EUR 29...
By Helgi Library - March 27, 2025
Redcare Pharmacy's net debt stood at EUR 69.8 mil and accounted for 13.7% of equity at the end of 2024. The ratio is up 7.60 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 20.0% in 2022 and a low o...
By Helgi Library - March 27, 2025
Redcare Pharmacy stock traded at EUR 132 per share at the end 2024 translating into a market capitalization of USD 2,740 mil. Since the end of 2019, the stock has appreciated by 203% representing an annual average growth of 24.8%. At the end of 2024, the...
By Helgi Library - March 27, 2025
Redcare Pharmacy stock traded at EUR 132 per share at the end 2024 implying a market capitalization of USD 2,740 mil. Since the end of 2019, stock has appreciated by 203% implying an annual average growth of 24.8% In absolute terms, the value of the company ...
By Helgi Library - May 22, 2023
Redcare Pharmacy made a net profit of EUR -45.5 mil with revenues of EUR 2,371 mil in 2024, down by 278% and up by 31.8%, respectively, compared to the previous year. This translates into a net margin of -1.92%. Historically, between 2013 - 2024, ...
By Helgi Library - May 22, 2023
Redcare Pharmacy stock traded at EUR 132 per share at the end 2024 translating into a market capitalization of USD 2,740 mil. Since the end of 2019, stock has appreciated by 203% representing an annual average growth of 24.8%. In absolute terms, the val...
By Helgi Library - May 22, 2023
Redcare Pharmacy made a net profit of EUR -45.5 mil with revenues of EUR 2,371 mil in 2024, down by 278% and up by 31.8%, respectively, compared to the previous year. This translates into a net margin of -1.92%. Historically, between 2013 and 2024, ...
Redcare Pharmacy, formerly Shop Apotheke Europe NV is a Netherlands-based Company that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company owns and operates online pharmacies in eight European countries such as in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Redcare Pharmacy has been growing its sales by 15.1% a year on average in the last 5 years. EBITDA has grown on average by 38.8% a year during that time to total of EUR 330 mil in 2030, or 5.50% of sales. That’s compared to 5.02% average margin seen in last five years.
The company netted EUR 162 mil in 2030 implying ROE of 15.8% and ROCE of 17.9%. Again, the average figures were 13.4% and 13.6%, respectively when looking at the previous 5 years.
Redcare Pharmacy’s net debt amounted to EUR -60.8 mil at the end of 2030, or -5.71% of equity. When compared to EBITDA, net debt was -0.185x, down when compared to average of 0.282x seen in the last 5 years.
Redcare Pharmacy stock traded at EUR 126 per share at the end of 2030 resulting in a market capitalization of USD 1,813 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 4.88x and price to earnings (PE) of 10.2x as of 2030.
Helgi Library 
